General Information of the Compound
Compound ID
CP0065472
Compound Name
[5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone
    Show/Hide
Synonyms
Debio 1347
    Show/Hide
Structure
Formula
C20H16N6O
Molecular Weight
356.389
Canonical SMILES
Cc1nc2ccc(cc2[nH]1)-n1ncc(C(=O)c2cc3ccccc3[nH]2)c1N
    Show/Hide
InChI
InChI=1S/C20H16N6O/c1-11-23-16-7-6-13(9-17(16)24-11)26-20(21)14(10-22-26)19(27)18-8-12-4-2-3-5-15(12)25-18/h2-10,25H,21H2,1H3,(H,23,24)
    Show/Hide
InChIKey
BEMNJULZEQTDJY-UHFFFAOYSA-N
CAS
1265229-25-1
Physicochemical Property
logP
3.35152
Rotatable Bonds
3
Heavy Atom Count
27
Polar Areas
105.38
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
5
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 66555680
SID: 152162439
ChEMBL ID
CHEMBL3907479
DrugBank ID
DB12903
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
IC50 = 6900 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Debio 1347 )
Drug Name Debio 1347
Company Debiopharm
Indication
Solid tumour/cancer
Phase 2
Breast cancer
Phase 1/2
Target(s)
Fibroblast growth factor receptor 1 (FGFR1)
Inhibitor
Fibroblast growth factor receptor 2 (FGFR2)
Inhibitor
Fibroblast growth factor receptor 3 (FGFR3)
Inhibitor